Market Overview:
The global conjunctivitis ophthalmic drugs market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The growth in this market can be attributed to factors such as rising prevalence of conjunctivitis, increasing awareness about eye health, and technological advancements in the field of ophthalmology. Based on type, the global conjunctivitis ophthalmic drugs market is segmented into smear and dripping. The smear segment is expected to account for a larger share of the global market during the forecast period. This can be attributed to its ease of use and low cost as compared to other types of medications available in the market for treating conjunctivitis. Based on application, the global Conjunctivitis Ophthalmic Drugs Market is segmented into hospital, clinic, household and others segments.
Product Definition:
Conjunctivitis, also known as pink eye, is an inflammation or infection of the conjunctiva – the thin membrane that lines the inside of the eyelids and covers the white part of the eyeball. Conjunctivitis ophthalmic drugs are used to treat this condition.
Smear:
A smear is a diagnostic test that involves placing a small amount of the suspected eye fluid on a glass slide and looking at it under the microscope. The presence or absence of white blood cells (WBCs) and RBCs in the sample can help determine if there is an infection present in the eye. A normal human genome has about 40,000 genes; however, during infection some of these genes are turned off to avoid damage.
Dripping:
Dripping is a medical condition, which occurs when the lacrimal (tear) gland produces insufficient quantity of tears. The condition can be due to any disorder in the facial nerve that controls the eyelid and tear production.
Application Insights:
Based on the application, the global market is segmented into hospital, clinic, household and others. The household segment held a major share in 2017 owing to rising awareness about eye care among consumers. Moreover, increasing spending power of individuals has encouraged manufacturers to develop high-quality products with affordable prices for better accessibility.
The hospital segment is expected to witness lucrative growth over the forecast period due to growing prevalence of ocular diseases coupled with an increase in number of surgeries being performed for conjunctival abrasion or corneal ulceration at hospitals or clinics. In addition, presence of prominent ophthalmic manufacturing companies such as Allergan plc., EyeVant Sciences Pvt Ltd.
Regional Analysis:
North America dominated the global conjunctivitis ophthalmic drugs market in 2017. This can be attributed to the presence of key players, high disease prevalence, and availability of advanced treatment options for patients. Moreover, increasing awareness levels among people regarding early diagnosis is also expected to drive regional growth over the forecast period.
Asia Pacific is expected to witness lucrative CAGR during the forecast period owing to rising healthcare expenditure by governments and private sectors in developing economies such as India and China along with other South East Asian countries. In addition, growing medical tourism industry due to low cost of treatment &air tickets coupled with favorable government policies are some factors that are anticipated boost regional growth over the next eight years time frame.
Growth Factors:
- Increasing prevalence of conjunctivitis
- Rising awareness about the benefits of ophthalmic drugs for treating conjunctivitis
- Growing demand for over-the-counter (OTC) ophthalmic drugs for the treatment of conjunctivitis
- Technological advancements in the field of ophthalmology that are helping to improve the diagnosis and treatment of conjunctivitis 5. increasing number of mergers and acquisitions in the Conjunctivitis Ophthalmic Drugs market
Scope Of The Report
Report Attributes
Report Details
Report Title
Conjunctivitis Ophthalmic Drugs Market Research Report
By Type
Smear, Dripping
By Application
Hospital, Clinic, Household, Others
By Companies
Novartis, Allergan, Bausch Health, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex, Akorn, Senju Pharmaceutical, Sun Pharmaceutical Industries
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
153
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Conjunctivitis Ophthalmic Drugs Market Report Segments:
The global Conjunctivitis Ophthalmic Drugs market is segmented on the basis of:
Types
Smear, Dripping
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Household, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Allergan
- Bausch Health
- Santen Pharmaceutical
- Lupin Pharmaceuticals
- Apotex
- Akorn
- Senju Pharmaceutical
- Sun Pharmaceutical Industries
Highlights of The Conjunctivitis Ophthalmic Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Smear
- Dripping
- By Application:
- Hospital
- Clinic
- Household
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Conjunctivitis Ophthalmic Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Conjunctivitis is an inflammation of the conjunctiva, a thin membrane that covers the eyeball. The most common cause of conjunctivitis is a viral infection, such as cold or flu. Other causes include allergies and contact lenses. Oftentimes, Conjunctivitis drugs are prescribed to treat the underlying cause of the infection.
Some of the key players operating in the conjunctivitis ophthalmic drugs market are Novartis, Allergan, Bausch Health, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex, Akorn, Senju Pharmaceutical, Sun Pharmaceutical Industries.
The conjunctivitis ophthalmic drugs market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Conjunctivitis Ophthalmic Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Conjunctivitis Ophthalmic Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Conjunctivitis Ophthalmic Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Conjunctivitis Ophthalmic Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Conjunctivitis Ophthalmic Drugs Market Size & Forecast, 2020-2028
4.5.1 Conjunctivitis Ophthalmic Drugs Market Size and Y-o-Y Growth
4.5.2 Conjunctivitis Ophthalmic Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Smear
5.2.2 Dripping
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Household
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Conjunctivitis Ophthalmic Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Conjunctivitis Ophthalmic Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Smear
9.6.2 Dripping
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Household
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Smear
10.6.2 Dripping
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Household
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Smear
11.6.2 Dripping
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Household
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Smear
12.6.2 Dripping
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Household
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Smear
13.6.2 Dripping
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Household
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Conjunctivitis Ophthalmic Drugs Market: Competitive Dashboard
14.2 Global Conjunctivitis Ophthalmic Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Allergan
14.3.3 Bausch Health
14.3.4 Santen Pharmaceutical
14.3.5 Lupin Pharmaceuticals
14.3.6 Apotex
14.3.7 Akorn
14.3.8 Senju Pharmaceutical
14.3.9 Sun Pharmaceutical Industries
